These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 20823824)
21. [Antioxidant activity of cytoflavin in experimental diffuse purulent peritonitis]. Kosinets VA Eksp Klin Farmakol; 2010 Jan; 73(1):30-2. PubMed ID: 20184286 [TBL] [Abstract][Full Text] [Related]
22. [The use of cytoflavin for the treatment of chronic brucellosis]. Shul'diakov AA; Liapina EP; Soboleva LA; Reshetnikov AA; Zubareva EV; Trubetskov AD; Anashchenko AV; Evdokimov AV Klin Med (Mosk); 2011; 89(2):56-8. PubMed ID: 21574446 [TBL] [Abstract][Full Text] [Related]
23. [The efficacy of cytoflavin in the treatment of burnout syndrome]. Chutko LS; Surushkina SY; Yakovenko EA; Rozhkova AV; Anisimova TI; Bondarchuk YL Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):66-70. PubMed ID: 26525625 [TBL] [Abstract][Full Text] [Related]
24. [The efficiency of cytoflavin and ozonotherapy in complex treatment of the myasthenia]. Drozd OA; Efremov VV; Dudarev IV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(1):46-9. PubMed ID: 23528494 [No Abstract] [Full Text] [Related]
25. [Dynamics of the symptoms of chronic ischemia during the treatment with cytoflavin]. Madzhidova EN; Usmanova DD; Baĭtursunova ZhM Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):57-62. PubMed ID: 23235414 [TBL] [Abstract][Full Text] [Related]
26. [Efficacy of cytoflavin in patients with hypertonic encephalopathy and constitutional venous insufficiency]. Belova LA; Mashin VV; Kolotik-Kameneva OIu; Belova NV; Byrina AV; Evstigneeva AIu; Abramova VV Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):21-6. PubMed ID: 23096033 [TBL] [Abstract][Full Text] [Related]
27. [Treatment of alcohol addiction syndrome with cytoflavin]. Belov VG; Parfenov IuA; Okovityĭ SV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6 Pt 2):54-7. PubMed ID: 23887469 [TBL] [Abstract][Full Text] [Related]
28. [An influence of cytoflavin on oxidative stress and activity of Na/K-ATPase of erythrocytes after brain trauma]. Deriugina AV; Shumilova AV Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):51-55. PubMed ID: 29265087 [TBL] [Abstract][Full Text] [Related]
29. [Efficacy of cytoflavin in the treatment of chronic cerebral ischemia]. Suslina ZA; Klocheva EG; Piradov MA; Rumiantseva SA; Romantsov MG; Kovalenko AL Klin Med (Mosk); 2010; 88(3):50-3. PubMed ID: 20608066 [TBL] [Abstract][Full Text] [Related]
30. [The use of neurometabolic treatment in the complex rehabilitation in poststroke patients]. Kovalchuck VV; Khafizova TL; Galkin AS Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(11):61-6. PubMed ID: 25591638 [TBL] [Abstract][Full Text] [Related]
31. [The use of cytoflavin in the complex treatment of patients with tick-borne encephalitis]. Selezneva AG; Petrova AG Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(7):68-9. PubMed ID: 23011438 [No Abstract] [Full Text] [Related]
32. [Efficacy of cytoflavin in the treatment of hypoxic-ischemic lesions of the nervous system in 1-month old children with transient neonatal hypothyroidism]. Strukov VI; Maksimova MN; Kuptsova TA; Lysev SF; Shcherbakova YG Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):17-20. PubMed ID: 26525615 [TBL] [Abstract][Full Text] [Related]
33. [The complex energy correction of chronic brain ischemia]. Suslina ZA; Rumiantseva SA; Tanashian MM; Skoromets AA; Klocheva EG; Fedin AI; Kovalenko AL; Silina EV; Sholomov II Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(3):25-30. PubMed ID: 21423112 [TBL] [Abstract][Full Text] [Related]
34. [Improvement of speech discrimination with cytoflavin in patients with chronic sensorineural deafness]. Zhuravskiĭ SG Vestn Otorinolaringol; 2010; (4):82-6. PubMed ID: 21105353 [No Abstract] [Full Text] [Related]
35. [Cytoflavin in polychemotherapy of breast cancer]. Kashuro VA; Glushkov SI; Zheregelia SN Antibiot Khimioter; 2010; 55(7-8):30-3. PubMed ID: 21140562 [TBL] [Abstract][Full Text] [Related]
36. [Efficacy of the complex drug cytoflavin in the treatment of consequences of mild brain injury]. Skoromets AA; Pugacheva EL Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3):31-6. PubMed ID: 20517223 [TBL] [Abstract][Full Text] [Related]
37. [An effect of cytoprotective therapy on stress resistance and compensatory abilities of patients with chronic cerebral ischemia]. Antipenko EA; Derugina AV; Gustov AV Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(12):74-78. PubMed ID: 26978497 [TBL] [Abstract][Full Text] [Related]
38. [Cytoflavin in the detoxification of alcohol-dependent patients]. Minko AI; Linskiĭ IV; Kuz'minov VN; Samoĭlova ES; Goloshchapov VV; Artemchuk KA Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6):35-40. PubMed ID: 23887449 [TBL] [Abstract][Full Text] [Related]
39. [Efficiency of cytoflavin in the treatment of somatoform disorders]. Chutko LS; Surushkina SY; Yakovenko EA; Anisimova TI; Prokopenko SM Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(1):21-24. PubMed ID: 28252599 [TBL] [Abstract][Full Text] [Related]
40. [The preventive treatment of stroke in patients with discirculatory encephalopathy with a depressive syndrome]. Erkebaeva SK; Nurguzhaev ES; Gafurov BG; Tuksanbaeva GU Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11):32-6. PubMed ID: 23257743 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]